EphA2 agonistic monoclonal antibodies and methods of use thereof

Details for Australian Patent Application No. 2004293034 (hide)

Owner MedImmune, LLC Purdue Research Foundation

Inventors Stewart, Jane C.; Carles-Kinch, Kelly; Kinch, Michael S.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004293034

PCT Pub. Number WO2005/051307

Priority 60/524,177 20.11.03 US

Parent 2003276832

Filing date 19 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 2 February 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051307 Priority application(s): WO2005/051307

21 August 2008 Amendment Made

  The nature of the amendment is: Amend the priority details to add divisional parent 2003276832 12 May 2003

9 October 2008 Alteration of Name

  The name of the applicant has been altered to Purdue Research Foundation; MedImmune, LLC

2 February 2012 Application Accepted

  Published as AU-B-2004293034

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293035-Methods of treating diseases and disorders by targeting multiple kinases

2004293031-Use of Shigella Invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo